A detailed history of Invesco Ltd. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 118,947 shares of AGIO stock, worth $7.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118,947
Previous 118,020 0.79%
Holding current value
$7.03 Million
Previous $5.09 Million 3.83%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$41.19 - $49.72 $38,183 - $46,090
927 Added 0.79%
118,947 $5.28 Million
Q2 2024

Aug 13, 2024

BUY
$27.55 - $48.83 $1.15 Million - $2.04 Million
41,818 Added 54.88%
118,020 $5.09 Million
Q1 2024

May 14, 2024

SELL
$21.32 - $34.81 $82,870 - $135,306
-3,887 Reduced 4.85%
76,202 $2.23 Million
Q4 2023

Feb 12, 2024

SELL
$19.97 - $24.53 $2.48 Million - $3.05 Million
-124,357 Reduced 60.83%
80,089 $1.78 Million
Q3 2023

Nov 13, 2023

BUY
$24.36 - $28.18 $3.14 Million - $3.63 Million
128,748 Added 170.08%
204,446 $5.06 Million
Q2 2023

Aug 11, 2023

BUY
$21.38 - $29.19 $79,341 - $108,324
3,711 Added 5.16%
75,698 $2.14 Million
Q1 2023

May 12, 2023

SELL
$21.74 - $30.93 $339,578 - $483,126
-15,620 Reduced 17.83%
71,987 $1.65 Million
Q4 2022

Feb 13, 2023

BUY
$24.81 - $31.52 $330,692 - $420,130
13,329 Added 17.94%
87,607 $2.46 Million
Q3 2022

Nov 14, 2022

SELL
$19.51 - $34.14 $90,545 - $158,443
-4,641 Reduced 5.88%
74,278 $2.1 Million
Q2 2022

Aug 15, 2022

BUY
$17.06 - $31.42 $38,930 - $71,700
2,282 Added 2.98%
78,919 $1.75 Million
Q1 2022

May 16, 2022

BUY
$26.68 - $34.81 $1.16 Million - $1.51 Million
43,504 Added 131.3%
76,637 $2.23 Million
Q4 2021

Feb 14, 2022

SELL
$29.58 - $49.78 $138,759 - $233,517
-4,691 Reduced 12.4%
33,133 $1.09 Million
Q3 2021

Nov 15, 2021

BUY
$41.92 - $58.18 $53,741 - $74,586
1,282 Added 3.51%
37,824 $1.75 Million
Q2 2021

Aug 17, 2021

SELL
$52.06 - $61.27 $242,026 - $284,844
-4,649 Reduced 11.29%
36,542 $2.01 Million
Q1 2021

May 17, 2021

BUY
$44.23 - $57.5 $61,347 - $79,752
1,387 Added 3.48%
41,191 $2.13 Million
Q4 2020

Feb 16, 2021

BUY
$33.21 - $46.54 $453,648 - $635,736
13,660 Added 52.25%
39,804 $1.73 Million
Q3 2020

Nov 16, 2020

SELL
$33.87 - $55.93 $41.2 Million - $68.1 Million
-1,217,095 Reduced 97.9%
26,144 $915,000
Q2 2020

Aug 14, 2020

BUY
$34.45 - $53.48 $833,276 - $1.29 Million
24,188 Added 1.98%
1,243,239 $66.5 Million
Q1 2020

May 15, 2020

SELL
$31.52 - $53.81 $5.8 Million - $9.9 Million
-184,021 Reduced 13.12%
1,219,051 $43.3 Million
Q4 2019

Feb 14, 2020

BUY
$30.08 - $50.59 $2.78 Million - $4.67 Million
92,293 Added 7.04%
1,403,072 $67 Million
Q3 2019

Nov 14, 2019

SELL
$32.4 - $49.58 $2.79 Million - $4.26 Million
-85,994 Reduced 6.16%
1,310,779 $42.5 Million
Q2 2019

Aug 14, 2019

BUY
$46.17 - $68.1 $25.7 Million - $37.9 Million
556,825 Added 66.29%
1,396,773 $69.7 Million
Q1 2019

May 15, 2019

SELL
$45.92 - $67.67 $78,339 - $115,445
-1,706 Reduced 0.2%
839,948 $56.6 Million
Q4 2018

Feb 14, 2019

BUY
$42.73 - $76.53 $36 Million - $64.4 Million
841,654 New
841,654 $38.8 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.